Haemodialysis of pyrazinamide in uraemic patients
Identifieur interne : 002646 ( Main/Exploration ); précédent : 002645; suivant : 002647Haemodialysis of pyrazinamide in uraemic patients
Auteurs : C. Lacroix [France] ; A. Hermelin [France] ; R. Guiberteau [France] ; C. Guyonnaud [France] ; J. Nouveau [France] ; H. Duwoos [France] ; O. Lafont [France]Source :
- European Journal of Clinical Pharmacology [ 0031-6970 ] ; 1989-05-01.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Pyrazinamide.
- chemical , metabolism : Pyrazinamide.
- chemical , pharmacokinetics : Pyrazinamide.
- blood : Uremia.
- Adult, Biotransformation, Chromatography, High Pressure Liquid, Female, Humans, Male, Renal Dialysis.
Abstract
Summary: The pharmacokinetics of PZA during haemodialysis were determined in 6 patients with chronic renal impairment after a single oral dose of 25.7 (1.9) mg·kg−1. The dialysis clearance of PZA and of its metabolites were: pyrazinamide 132 ml·min−1; pyrazinoic acid 121 ml·min−1; 5-hydroxy-pyrazinamide 107 ml·min−1; 5-hydroxy-pyrazinoic acid 118 ml·min−1. The average amount extracted during a dialysis session of 4.1 h was 926 mg after an oral dose of 1700 mg. The high dialysability shows that PZA can property be administered at the end of each dialysis session in the usual dose of 25 to 30 mg·kg−1.
Url:
DOI: 10.1007/BF00679791
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000180
- to stream Istex, to step Curation: 000180
- to stream Istex, to step Checkpoint: 001289
- to stream Main, to step Merge: 002719
- to stream PubMed, to step Corpus: 000449
- to stream PubMed, to step Curation: 000449
- to stream PubMed, to step Checkpoint: 000449
- to stream Ncbi, to step Merge: 000484
- to stream Ncbi, to step Curation: 000484
- to stream Ncbi, to step Checkpoint: 000484
- to stream Main, to step Merge: 002666
- to stream Main, to step Curation: 002646
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Haemodialysis of pyrazinamide in uraemic patients</title>
<author><name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C." last="Lacroix">C. Lacroix</name>
</author>
<author><name sortKey="Hermelin, A" sort="Hermelin, A" uniqKey="Hermelin A" first="A." last="Hermelin">A. Hermelin</name>
</author>
<author><name sortKey="Guiberteau, R" sort="Guiberteau, R" uniqKey="Guiberteau R" first="R." last="Guiberteau">R. Guiberteau</name>
</author>
<author><name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
</author>
<author><name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
</author>
<author><name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
</author>
<author><name sortKey="Lafont, O" sort="Lafont, O" uniqKey="Lafont O" first="O." last="Lafont">O. Lafont</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B727ECFFFAE073551F411AEA83F18F3A11ABF76C</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1007/BF00679791</idno>
<idno type="url">https://api.istex.fr/document/B727ECFFFAE073551F411AEA83F18F3A11ABF76C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000180</idno>
<idno type="wicri:Area/Istex/Curation">000180</idno>
<idno type="wicri:Area/Istex/Checkpoint">001289</idno>
<idno type="wicri:doubleKey">0031-6970:1989:Lacroix C:haemodialysis:of:pyrazinamide</idno>
<idno type="wicri:Area/Main/Merge">002719</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2612545</idno>
<idno type="wicri:Area/PubMed/Corpus">000449</idno>
<idno type="wicri:Area/PubMed/Curation">000449</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000449</idno>
<idno type="wicri:Area/Ncbi/Merge">000484</idno>
<idno type="wicri:Area/Ncbi/Curation">000484</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000484</idno>
<idno type="wicri:doubleKey">0031-6970:1989:Lacroix C:haemodialysis:of:pyrazinamide</idno>
<idno type="wicri:Area/Main/Merge">002666</idno>
<idno type="wicri:Area/Main/Curation">002646</idno>
<idno type="wicri:Area/Main/Exploration">002646</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Haemodialysis of pyrazinamide in uraemic patients</title>
<author><name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C." last="Lacroix">C. Lacroix</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName><settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hermelin, A" sort="Hermelin, A" uniqKey="Hermelin A" first="A." last="Hermelin">A. Hermelin</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName><settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Guiberteau, R" sort="Guiberteau, R" uniqKey="Guiberteau R" first="R." last="Guiberteau">R. Guiberteau</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName><settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName><settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName><settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Unités de Pharmacocinétique, de Néphrologie, de Pneumologie, Centre Hospitalier Général, Le Havre</wicri:regionArea>
<placeName><settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lafont, O" sort="Lafont, O" uniqKey="Lafont O" first="O." last="Lafont">O. Lafont</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Chimie Organique, Centre de Pharmacochimie du Madrillet, Faculté de Médecine et de Pharmacie de Rouen, Saint-Etienne du Rouvray</wicri:regionArea>
<wicri:noRegion>Saint-Etienne du Rouvray</wicri:noRegion>
<wicri:noRegion>Saint-Etienne du Rouvray</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">European Journal of Clinical Pharmacology</title>
<title level="j" type="abbrev">Eur J Clin Pharmacol</title>
<idno type="ISSN">0031-6970</idno>
<idno type="eISSN">1432-1041</idno>
<imprint><publisher>Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="1989-05-01">1989-05-01</date>
<biblScope unit="volume">37</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="309">309</biblScope>
<biblScope unit="page" to="311">311</biblScope>
</imprint>
<idno type="ISSN">0031-6970</idno>
</series>
<idno type="istex">B727ECFFFAE073551F411AEA83F18F3A11ABF76C</idno>
<idno type="DOI">10.1007/BF00679791</idno>
<idno type="ArticleID">BF00679791</idno>
<idno type="ArticleID">Art20</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0031-6970</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Biotransformation</term>
<term>Chromatography, High Pressure Liquid</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Pyrazinamide (blood)</term>
<term>Pyrazinamide (metabolism)</term>
<term>Pyrazinamide (pharmacokinetics)</term>
<term>Renal Dialysis</term>
<term>Uremia (blood)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Pyrazinamide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Pyrazinamide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Pyrazinamide</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Uremia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Biotransformation</term>
<term>Chromatography, High Pressure Liquid</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Renal Dialysis</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Summary: The pharmacokinetics of PZA during haemodialysis were determined in 6 patients with chronic renal impairment after a single oral dose of 25.7 (1.9) mg·kg−1. The dialysis clearance of PZA and of its metabolites were: pyrazinamide 132 ml·min−1; pyrazinoic acid 121 ml·min−1; 5-hydroxy-pyrazinamide 107 ml·min−1; 5-hydroxy-pyrazinoic acid 118 ml·min−1. The average amount extracted during a dialysis session of 4.1 h was 926 mg after an oral dose of 1700 mg. The high dialysability shows that PZA can property be administered at the end of each dialysis session in the usual dose of 25 to 30 mg·kg−1.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<settlement><li>Le Havre</li>
</settlement>
</list>
<tree><country name="France"><noRegion><name sortKey="Lacroix, C" sort="Lacroix, C" uniqKey="Lacroix C" first="C." last="Lacroix">C. Lacroix</name>
</noRegion>
<name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
<name sortKey="Guiberteau, R" sort="Guiberteau, R" uniqKey="Guiberteau R" first="R." last="Guiberteau">R. Guiberteau</name>
<name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
<name sortKey="Hermelin, A" sort="Hermelin, A" uniqKey="Hermelin A" first="A." last="Hermelin">A. Hermelin</name>
<name sortKey="Lafont, O" sort="Lafont, O" uniqKey="Lafont O" first="O." last="Lafont">O. Lafont</name>
<name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002646 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002646 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/France |area= LeHavreV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:B727ECFFFAE073551F411AEA83F18F3A11ABF76C |texte= Haemodialysis of pyrazinamide in uraemic patients }}
This area was generated with Dilib version V0.6.25. |